Event Type: single-event

WEBINAR 2: Thursday, June 24 – 6PM CT UTERINE FIBROIDS & Elagolix+Estradiol/NETA, indicated for heavy menstrual bleeding associated with uterine leiomyomas in pre-menopausal women Uterine fibroids, also called leiomyomas, are estrogen and progesterone-dependent non-cancerous tumors of the uterus and are the most common type of benign tumor in women of reproductive age. Traditionally, uterine fibroids Read moreDAPA & AbbVie – Women’s Health Sessions – Session 2 – Thursday, June 24

  WEBINAR 1: Wednesday, June 23, 2021 – 6PM CT  Endometriosis and Elagolix, indicated for moderate to severe endometriosis pain. One of the most common gynecologic disorders in the U.S., and affecting  roughly 10% (190 million) of reproductive age women and girls worldwide, endometriosis is a highly estrogen-dependent, chronic, inflammatory disease characterized by the growth Read moreDAPA & AbbVie – Women’s Health Sessions – Session 1 – Wednesday, June 23

Rare Genetic Diseases of Obesity:   Challenges and Patient Cases – Virtual Meeting Thursday, May 6, 2021 6:30 PM The disease education event will explain the role of the hypothalamic signaling pathway in appetite, energy and weight regulation.  The presentation will include how impairments in the melanocortin-4 receptor (MC4R) pathway may lead to insatiable hunger and Read moreMay 2021 – Rhythm Pharmaceuticals – DAPA – Rare Genetic Diseases of Obesity: Challenges and Patient Cases

  You’re invited to join our April 2021 Meeting! Title Use of Dapagliflozin in Patients with Heart Failure with reduced Ejection Fraction (HFrEF) Presented by Jessica Hart, PharmD, BCACP – Medical Science Liaison, Cardiovascular and Metabolic – North Texas, Oklahoma, AstraZeneca When Thursday, April 8, 2021 at 6:30 PM This is a VIRTUAL meeting Are Read moreApril 2021 DAPA Meeting – AstraZeneca – Use of Dapagliflozin in Patients with Heart Failure with reduced Ejection Fraction (HFrEF)

February 2021 DAPA Meeting is here! FREE TEXAS LAW CE FOR DAPA/TPA MEMBERS! Title: Texas State Board of Pharmacy Law Review and Updates Presented by: Allison Vordenbaumen Benz, R.Ph., M.S. Executive Director/Secretary Texas State Board of Pharmacy When: Thursday, February 4, 2021 at 6:30 PM This is a FREE Texas Law CE for DAPA/TPA members! PLEASE READ: This Read moreFebruary 2021 DAPA Meeting is here! FREE TEXAS LAW CE FOR DAPA/TPA MEMBERS!

DAPA November 2020 Meeting with Pfizer – Dermatology Topic: Pfizer Inflammation & Immunology Cross-Indication Pipeline Host: Kristine Bucasas Field Medical Director, Dermatology (TX, AR) Date: Thursday, November 5, 2020 Time: 6:30 pm, Central Time Register today! Everyone is welcome to the meeting. You will receive an email to join the meeting after you have registered and Read moreDAPA November 2020 Meeting with Pfizer – Dermatology